Attenuation of Tissue Thrombosis and Hemorrhage by ala-TFPI Does not Account for Its Protection against E. coli

Summary

This study was designed to determine the effect of a delayed infusion (T+120 min) of alanyl tissue factor pathway inhibitor (ala-TFPI) on the response to LD₁₀₀ E. coli. We hypothesized that baboons treated with a low dose of TFPI (5 mg/kg) which did not survive would exhibit thrombosis, infarction and hemorrhage of target tissues such as that seen in untreated animals infused with LD₁₀₀ E. coli. Eight baboons were infused with 5 mg/kg of ala-TFPI over a 10 h period beginning immediately after a 2 h infusion of LD₁₀₀ E. coli (experimental group). Four baboons were infused with E. coli followed by a 10 h infusion of saline (control group). Of the 12 baboons, the 11 non-survivors (TFPI = 7 out of 8; controls = 4 out of 4) were evaluated for the extent of thrombosis, necrosis, hemorrhage, and congestion of target tissues and for changes in clinical chemical parameters. We expected that failure to protect would correlate with failure to inhibit thrombosis of target tissue (8). Surprisingly ala-TFPI significantly inhibited thrombosis, hemorrhage and necrosis of adrenal and renal tissues and attenuated the rise in creatinine in the 7 treated non-survivors. The lungs of these non-survivors, however, exhibited intra-alveolar fibrin and a mild degree of hemorrhage and edema. We concluded that low doses of ala-TFPI begun as late as T+120 in minutes failed to protect against the lethal effects of LD₁₀₀ E. coli in spite of completely preventing thrombosis and hemorrhage in target organs, and that thrombosis, infarction and hemorrhage of adrenal and renal tissue are not part of the lethal chain of events in this IV model of E. coli sepsis.

• References

• 1 Rapaport SI. The extrinsic pathway inhibitor: a regulator of tissue factor-dependent blood coagulation. Thromb Haemost 1991; 66 (01) 6-5.
• 2 Nemerson Y. The reaction between bovine brain tissue factor and factors VII and X. Biochem 1966; 5: 601-8.
• 3 Osterud B, Rapaport SI. Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiation blood coagulation. Proc Nat Acad Sci USA 1977; 74: 5260-4.
• 4 Drake TA, Morrissey JH, Edgington T. Selective cellular expression of tissue factor in human tissues: Implications for disorders of hemostasis and thrombosis. Amer J Pathol 1989; 1087-97.
• 5 Risberg B, Adreasson S, Eriksson E. Disseminated intravascular coagulation. Acta Anaesthesiol Scand 1991; 35: 60-71.
• 6 Sandset M, Warn-Cramer BJ, Rao Vijaya M, Maki SL, Rapaport SI. Depletion of extrinsic pathway inhibitor (EPI) sensitizes rabbits to disseminated intravascular coagulation induced with tissue factor: evidence supporting a physiological role of EPI as a natural anticoagulant. Proc Nat Acad Sci USA 1991; 88: 708-12.
• 7 Creasey AA, Chang ACK, Feigen L, Wun TC, Taylor FB, Hinshaw LB. Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock. Journal of Clin Invest 1993; 91: 2850-60.
• 8 Carr C, Bild GS, Chang ACK, Peer GT, Palmier MO, Frazier RB, Gustafson ME, Wun PC, Creasey AA, Hinshaw LB, Taylor Jr FB, Galluppi GR. Recombinant E. coli-derived tissue factor pathway inhibitor reduces coagulopathic and lethal effects in the baboon gram negative model of septic shock. Circ Shock 1995; 44: 126-37.
• 9 Hinshaw LB, Brackett DJ, Archer LT, Beller BK, Wilson MF. Detection of the hyperdynamic state of sepsis in the baboon during lethal E. coli infusion. J Trauma 1982; 23: 361-5.
• 10 Hougie C. Methods for estimating fibrinogen concentration - thrombin time test. In: Hematology. Williams WJ, Beutler E, Erslev AJ, Lichtman MA. eds. McGraw-Hill; New York: 1983. p 1667.
• 11 Wellcome Research Laboratories.. Fibrinogen Degradation Products: Thrombo-Wellcotest (Rapid Latex Kit). Purley, Surrey, UK: Southern Press; 1984
• 12 Jaffe M. Über den Niederschlag welchen Pikrinsäure in normalem Harn erzeugt und über eine neue Reaktion des Kreatinins. Hoppe Seylers Zeitschrift Physikalische Chemie, 1986; 10: 391.
• 13 Taylor Jr. FB. Role of tissue factor in the coagulant and inflammatory response to LD₁₀₀ E. coli sepsis and in the early diagnosis of DIC in the baboon. In. DIC: Pathogenesis, Diagnosis and Therapy of Disseminated Intravascular Fibrin Formation. Muller-Berghaus G.. ed. Elsevier Science Publishers; 1993. pp 19-32.
• 14 Rottingen JA, Enden T, Camerer E, Iversen JG, Prydz H. Binding of human factor VIIa to tissue factor induces cytosolic Ca²⁺ signals in J82 cells, transfected COS-1 cells, Madin-Darby canine kidney cells and in human endothelial cells induced to synthesize tissue factor. J Biol Chem 1995; 270 (09) 4650-60.
• 15 Camerer E, Rottingen JA, Iversen JG, Prydz H. Coagulation factors VII and X induce Ca²⁺ oscillations in Madin-Darby canine kidney cells only when proteolytically active. J. Biol Chem 1996; 271: 29034.
• 16 Taylor FB, Chang AK, Mather T, Blick KE, Catlett R, Lockhart MS, Esmon CT. DEGR-factor Xa blocks disseminated intravascular coagulation initiated by E. coli without preventing shock or organ damage, Blood 1991; 78: 364-71.